Viability testing to guide myocardial revascularisation in patients with heart failure

被引：2
作者：
Cahill T.J. [1 ]
Kharbanda R.K. [1 ]
机构：
[1] Oxford Heart Centre, Oxford University Hospitals NHS Foundation Trust, Headley Way, Oxford
来源：
Indian Journal of Thoracic and Cardiovascular Surgery | 2018年 / 34卷 / Suppl 3期
关键词：
Coronary artery disease; Heart failure; Ischaemic cardiomyopathy;
D O I：
10.1007/s12055-017-0637-4
中图分类号：
学科分类号：
摘要：
Myocardial revascularisation has the potential to restore ventricular function and improve survival in patients with heart failure due to underlying coronary artery disease. Viability testing is routinely used to identify which patients are likely to benefit, given that revascularisation may entail substantial procedural risk. However, while the concept of viability testing and revascularisation of patients with ‘hibernating myocardium’ is strongly supported by observational series, randomised studies have failed to demonstrate clear benefit. This divergence in the evidence base is reflected in current European and US guidelines, in which viability testing has a class II recommendation. In this article, we review the current evidence for routine viability testing prior to revascularisation of patients with heart failure, outline its use in clinical practice and discuss ongoing trials in the field. © 2018, The Author(s).
引用
收藏
页码：206 / 212
页数：6
相关论文
共 40 条
  • [1] Gheorghiade M., Sopko G., De Luca L., Et al., Navigating the crossroads of coronary artery disease and heart failure, Circulation, 114, pp. 1202-1213, (2006)
  • [2] Rahimtoola S.H., Coronary bypass surgery for chronic angina--1981. A perspective, Circulation, 65, pp. 225-241, (1982)
  • [3] Allman K.C., Shaw L.J., Hachamovitch R., Udelson J.E., Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction: A meta-analysis, J Am Coll Cardiol, 39, pp. 1151-1158, (2002)
  • [4] Carluccio E., Biagioli P., Alunni G., Et al., Patients with hibernating myocardium show altered left ventricular volumes and shape, which revert after revascularization: Evidence that dyssynergy might directly induce cardiac remodeling, J Am Coll Cardiol., 47, pp. 969-977, (2006)
  • [5] van Deursen V.M., Urso R., Laroche C., Damman K., Dahlstrom U., Tavazzi L., Et al., Comorbidities in patients with heart failure: An analysis of the European Heart Failure Pilot Survey, Eur J Heart Fail., 16, pp. 103-111, (2014)
  • [6] Stahle E., Bergstrom R., Edlund B., Et al., Influence of left ventricular function on survival after coronary artery bypass grafting, Ann Thorac Surg., 64, pp. 437-444, (1997)
  • [7] Gossl M., Faxon D.P., Bell M.R., Holmes D.R., Gersh B.J., Complete versus incomplete revascularization with coronary artery bypass graft or percutaneous intervention in stable coronary artery disease, Circ Cardiovasc Interv., 5, pp. 597-604, (2012)
  • [8] Rahimtoola S.H., The hibernating myocardium, Am Heart J., 117, pp. 211-221, (1989)
  • [9] Shah B.N., Khattar R.S., Senior R., The hibernating myocardium: Current concepts, diagnostic dilemmas, and clinical challenges in the post-STICH era, Eur Heart J., 34, pp. 1323-1336, (2013)
  • [10] Rahimtoola S.H., A perspective on the three large multicenter randomized clinical trials of coronary bypass surgery for chronic stable angina, Circulation., 72, pp. 123-135, (1985)
1234